Cookie Consent by Free Privacy Policy Generator Update cookies preferences

Session 27

OESO-SEMPIRE 16th World Conference | Esophagus 2024 | Strasbourg | April 23-26, 2024 | Venue: IRCAD France

<  back to Program at a glance
<  back to all the scientific sessions


Session 27: ENT: Airway Reflux

Friday, April 26, 9:00 – 10:30 am
Rooms C.L.E.M.

Chairs: Thomas L. Carroll (USA) – Nikki Johnston (USA)

  1. When should you use PPIs for LPR and when should you not? – Serhat Bor (Turkey)
  2. What is the rate of pepsin saliva positivity in asymptomatic individuals and does multi-sampling help us choose treatment? – Jacqueline Allen (New Zealand)
  3. How do anti-pepsin therapies protect against reflux-mediated damage? – Simon Blaine-Sauer (USA)
  4. What is the aetiologic evidence for reflux in adult and pediatric subglottic stenosis? – Derrick R. Randall (Canada)
  5. What are the interactions between laryngopharyngeal reflux and chronic cough? – Jonathan Bock (USA)
  6. How do we determine when the cause of an LPR symptom is due to other laryngeal pathology? – Thomas L.  Carroll (USA)
  7. What has been learned about GERD from the lung transplant world? – Sumeet Mittal (USA)